Seeking Alpha

Pluristem Therapeutics (PSTI +4%) pops on reports that the FDA has granted orphan status for its...

Pluristem Therapeutics (PSTI +4%) pops on reports that the FDA has granted orphan status for its PLX Cells to treat aplastic anemia.
Comments (1)
  • smallcap sleuth
    , contributor
    Comments (184) | Send Message
     
    How come the likely profitability is so far into the future if this can be brought to market sooner?
    21 Feb 2013, 05:03 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs